HCV treatment found to be similarly effective in prison and nonprison populations

被引：0
|
作者：
McCarthy, Jacob
机构：
来源：
FUTURE VIROLOGY | 2012年 / 7卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：1053 / 1053
页数：1
相关论文
共 50 条
  • [31] HCV-hepatocellular carcinoma: New findings and hope for effective treatment
    Dash, S
    Haque, S
    Joshi, V
    Prabhu, R
    Hazari, S
    Fermin, C
    Garry, R
    MICROSCOPY RESEARCH AND TECHNIQUE, 2005, 68 (3-4) : 130 - 148
  • [32] Sofosbuvir/Ledipasvir Fixed Dose Combination Is Safe and Effective in HCV Infected Populations Including Decompensated Patients and Patients With Prior Sofosbuvir Treatment Experience
    Gane, Edward
    Hyland, Rob H.
    Pang, Phil
    Symonds, William T.
    McHutchison, John G.
    Stedman, Catherine A.
    GASTROENTEROLOGY, 2014, 146 (05) : S904 - S905
  • [33] Declining HCV incidence following rapid HCV treatment scale-up in a prison network in Australia: Evidence of treatment as prevention from the SToP-C study
    Dore, Gregory
    Hajarizadeh, Behzad
    Grebely, Jason
    Byrne, Marianne
    Marks, Pip
    Amin, Janaki
    Mcmanus, Hamish
    Butler, Tony
    Vickerman, Peter
    Martin, Natasha
    Mchutchison, John
    Brainard, Diana
    Treloar, Carla
    Lloyd, Andrew
    JOURNAL OF HEPATOLOGY, 2020, 73 : S127 - S127
  • [34] ILIT is a similarly effective treatment of grass pollen induced rhinitis for patients with moderate/severe and mild symptoms
    Skaarup, S. H.
    Schmid, J. M.
    Skjold, T.
    Graumann, O.
    Hoffmann, H. J.
    ALLERGY, 2016, 71 : 60 - 61
  • [35] CBT, SSRI or both are similarly effective for panic disorder 1-year post-treatment
    van Apeldoorn, Franske J.
    Schuurmans, Josien
    EVIDENCE-BASED MENTAL HEALTH, 2010, 13 (04) : 125 - 125
  • [36] Chronic hepatitis C treatment in prison settings: eradication model for difficult to reach populations
    Farley, J.
    Hakobyan, V.
    Farley, J-R
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 62 - 62
  • [37] Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations
    Moreno, Gigi A.
    Wang, Alice
    Gonzalez, Yuri Sanchez
    Espinosa, Oliver Diaz
    Vania, Diana K.
    Edlin, Brian R.
    Brookmeyer, Ronald
    VALUE IN HEALTH, 2017, 20 (06) : 736 - 744
  • [38] Changing Demographics Among Populations Prescribed HCV Treatment, 2013-2017
    Tsai, Naoky
    Bacon, Bruce
    Curry, Michael
    Flamm, Steven L.
    Milligan, Scott
    Wick, Nicole
    Younossi, Zobair
    Afdhal, Nezam
    AMERICAN JOURNAL OF MANAGED CARE, 2019, 25 (07): : 319 - 323
  • [39] THE COST-EFFECTIVENESS OF HCV ANTIVIRAL TREATMENT FOR INJECTING DRUG USER POPULATIONS
    Martin, N. K.
    Vickerman, P.
    Foster, G. R.
    Miners, A.
    Hutchinson, S. J.
    Goldberg, D. J.
    Hickman, M.
    GUT, 2011, 60 : A25 - A25
  • [40] Correlates of Successful HCV Treatment in HIV Co-Infected Vulnerable Populations
    Conway, Brian
    HEPATOLOGY, 2015, 62 : 1131A - 1132A
12345